Enbrel 50 MG/ML syringeml
Ended Awarded Last action
- Contract number
- SPE2DR26FG3HH
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $70,376
Award facts
- Contract value 100% obligated
- $70,376.32 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., received a delivery order award from the Defense Logistics Agency (DLA) on January 13, 2026, for the supply of Enbrel 50 mg/ml syringes, valued at $70,376.32 with a completion date of January 14, 2026. This was a competitively awarded, firm fixed-price delivery order with no set-aside designation. The contract will be performed in Conshohocken, Pennsylvania, where Amerisourcebergen maintains its corporate headquarters and primary operations as a major pharmaceutical distributor serving federal medical procurement needs.
This delivery order is issued under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. Enbrel, a biologic treatment commonly used for rheumatoid arthritis and other autoimmune conditions, represents a critical medical commodity within the company's federal contract portfolio supporting Defense Health Agency and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FG3HH?
SPE2DR26FG3HH was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26FG3HH worth?
The government has obligated $70,376 on SPE2DR26FG3HH.
Is contract SPE2DR26FG3HH an order under another contract?
Yes. SPE2DR26FG3HH is a delivery order under SPE2DR25D3016, an indefinite delivery contract.
Was contract SPE2DR26FG3HH competed?
The extent of competition for SPE2DR26FG3HH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award